Stanley Rhonda L. 4
4 · Adhera Therapeutics, Inc. · Filed Nov 5, 2019
Insider Transaction Report
Form 4
Stanley Rhonda L.
SVP Finance & Accounting
Transactions
- Award
Options to purchase common stock
2019-11-01+350,000→ 350,000 totalExercise: $0.09Exp: 2029-11-01→ common stock (350,000 underlying)
Footnotes (1)
- [F1]Options to purchase 75,000 shares are exercisable immediately, options to purchase 75,000 shares shall vest on each of November 1, 2020, November 1, 2021 and November 1, 2022, options to purchase 25,000 shares shall vest on such date (if any) that the Issuer determines that the "Revenue Target" (as defined in the Employment Agreement dated October 29, 2019 between the Issuer and the reporting person (the "Employment Agreement")) is achieved, and options to purchase 25,000 shares shall vest on such date (if any) that the Issuer determines that the "Stock Price Target" (as defined in the Employment Agreement) has been achieved.